Investors

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

Shuang Yang, Scientist, China

Second quarter 2024 results

Second quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.

Thursday July 25, 2024
14:30 - 16:00 CET (8:30am – 10am EST)

Upcoming events

25Jul

2024

Second quarter 2024 results

Second quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EST)

Quarterly Results

Discover more

15Aug

2024

TD Cowen Hot Wheels Bus Tour

11:45 - 12:45 EST

Broker Conference

4Sep

2024

J.P. Morgan European Healthcare CEO Call Series

15:00 - 16:00 CEST

Broker Conference

Press releases

July 17, 2024
Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
July 3, 2024
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
June 28, 2024
Media Update: Frexalimab new phase 2 data showed reduction of key biomarker of nerve cell damage in relapsing MS
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

2023 20-F

Presenting our 2023 FORM 20-F.

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com